Tag: checkpoint blockade inhibitor


UTHSC Team Published in Cell Reports

|

Despite thousands of studies, the role obesity plays in cancer risk and outcomes is still not fully understood. Obesity is generally associated with poor survival in cancer patients. Yet it appears to improve the effects of new class of immunotherapy drugs in a number of cancer types, including melanoma, ovarian, and certain lung and kidney cancers.… Read More